genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
27-Year-Old Suspect Charged in Murder of Max Planck Institute Scientist
News
Removing Anthrax Bacterial Armor May Lead to New Therapies
Tech Exclusives
Gilead Expands Galapagos Stake, Filgotinib Role, Pipeline Access in $5.1B R&D…
Neuroscience
Multiple Sclerosis Patients’ Cerebrospinal Fluid Offers New Clues for Potential Therapeutic…
Tech Exclusives
Genmab Partners on Cancer Antibodies with BliNK Biomedical, Launches $503M U.S….
Insights
Insights
Top 10 Biopharma IPOs of January–June 2019
Tech Exclusives
A Toolbox for Keeping CRISPR in Check
Tech Exclusives
Drones Land in the Cell and Gene Therapy Space
Tech Exclusives
An Integrated Digital Vision for Biomanufacturing’s Future
Tech Exclusives
CRISPR and LASER ART Eliminate HIV from Mice
A-Lists
Insights
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
July 2019 Vol. 39 No. 7
25 Up-and-Coming Gene Therapies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Removing Anthrax Bacterial Armor May Lead to New Therapies
Tech Exclusives
Gilead Expands Galapagos Stake, Filgotinib Role, Pipeline Access in $5.1B R&D…
Neuroscience
Multiple Sclerosis Patients’ Cerebrospinal Fluid Offers New Clues for Potential Therapeutic…
Tech Exclusives
Genmab Partners on Cancer Antibodies with BliNK Biomedical, Launches $503M U.S….
Magazine
July 2019 Vol. 39 No. 7
CRISPR-Accelerated Gene Drives Pump the Brakes
July 2019 Vol. 39 No. 7
CRISPR Cinema: Scenes from the Cutting Edge
Tech Exclusives
Immunotherapy Targets Emerging Infectious Diseases
July 2019 Vol. 39 No. 7
Single-Cell Sequencing Sifts through Multiple Omics
Tech Exclusives
Bioreactor Design Adapts to Biopharma’s Changing Needs
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
GENcast: A Biological GPS That Guides Awareness through Cellular Space
July 2019 Vol. 39 No. 7
Full-Length Transcript Sequencing—No Assembly Required
July 2019 Vol. 39 No. 7
Plasma Proteomics with NanoLC-MS
July 2019 Vol. 39 No. 7
Advanced Mass Spectrometry Drives Translational Cancer Biomarker Research beyond Discovery
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Pain
Pain
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pain
Gut Microbiome Changes Correlate with Non-Gut Pain
Pain
Opioid Alternative May Be Found in Lethal Pufferfish Toxin
Pain
Lilly Licenses Centrexion Non-Opioid Pain Candidate for Up to $1B
Pain
Insys Shares Plunge After Warning of Chapter 11 Bankruptcy Filing
Pain
Is Fibromyalgia Caused by Insulin Resistance?
Pain
Lundbeck to Acquire Abide for Up to $400M, Bolstering Neurology Pipeline
Pain
Insys Founder, Four Former Executives Convicted of RICO Conspiracy Tied to...
Pain
Pfizer, Lilly Weigh Tanezumab’s Future Following Mixed Phase III Results
Pain
Opiant Eyes Q2 Launch for Pivotal Trial of Opioid Overdose Candidate...
Pain
Neurons Controlled Using Anti-Smoking Drug
Pain
Merck, King’s Launch $344M+ Chronic Pain Drug Collaboration
Pain
Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II...
Pain
Why Some Injuries Are More Painful than Others
Pain
Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M
Pain
Lilly, Dicerna Launch $3.7B+ RNAi Collaboration
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
